BERTRAM PITT, MD
Osteopathic Medicine in Ann Arbor, MI
License number
Michigan 4301039549
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Michigan 4301039549
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
1500 Floor Cardiovascular Ctr, Ann Arbor, MI 48109
Phone
(888) 287-1082
(734) 936-2047
(734) 936-2047
Organization information
See more information about BERTRAM PITT at bizstanding.comBertram Pitt MD
1500 E Medical Ctr Dr, Ann Arbor, MI 48109
Industry:
Internist
Phone:
(888) 287-1082 (Phone)
Bertram D. Pitt
Professional information
Bertram Pitt, Ann Arbor MI
Specialties:
Internist
Address:
1500 E Medical Center Dr, Ann Arbor, MI 48109
Education:
University of Basel, Faculty of Medicine - Doctor of Medicine
Johns Hopkins Hospital - Fellowship - Cardiology
Johns Hopkins Hospital - Fellowship - Cardiology
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Cardiovascular Disease (Internal Medicine)
Dr. Bertram Pitt, Ann Arbor MI - MD (Doctor of Medicine)
Specialties:
Cardiology
Address:
1500 E Medical Center Dr, Ann Arbor 48109
(888) 287-1082 (Phone)
(888) 287-1082 (Phone)
Certifications:
Cardiovascular Disease, 1975, Internal Medicine, 1973
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1500 E Medical Center Dr, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
Education:
Medical School
University of Basel / Medical Faculty
Beth Israel Hosp
Beth Israel Deaconess Medical Center
The Johns Hopkins Hospital
University of Basel / Medical Faculty
Beth Israel Hosp
Beth Israel Deaconess Medical Center
The Johns Hopkins Hospital
Bertram D Pitt, Ann Arbor MI
Specialties:
Internal Medicine, Cardiovascular Disease, Cardiology
Work:
University of Michigan Medical School
1500 E Medical Center Dr, Ann Arbor, MI 48109
1500 E Medical Center Dr, Ann Arbor, MI 48109
Education:
Universitat Basel (1959)
Method For The Diagnosis And Treatment Of Salt Sensitivity And Related Conditions
US Patent:
2010003, Feb 11, 2010
Filed:
Jan 17, 2008
Appl. No.:
12/522248
Inventors:
Maria Carolina Delgado - Doral FL, US
Bertram Pitt - Ann Arbor MI, US
Bertram Pitt - Ann Arbor MI, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
A61K 33/04, A61K 33/00, C12Q 1/02, A61K 31/585, A61K 31/546, A61K 31/4406, A61K 31/4155, A61K 31/41, A61K 31/4178, A61K 31/4168, A61K 31/403, A61K 31/40, A61K 31/355, A61K 31/197, A61K 31/135, A61K 31/138, A61K 31/04
US Classification:
424702, 424722, 435 29, 514173, 5142225, 514355, 514381, 514382, 514397, 514401, 514411, 514412, 514423, 514458, 514567, 514651, 514652, 514742
Abstract:
The present invention provides methods for measuring, detecting, diagnosing, treating, and researching salt sensitivity and related conditions. In particular, the present invention provides methods for measuring, detecting, diagnosing, treating, and researching salt sensitivity through measuring aberrant red blood cell based potassium efflux levels. In addition, the present invention provides methods for treating conditions involving salt sensitivity (e.g., hypertension), preventing the onset of conditions involving salt sensitivity, identifying individuals at risk for developing salt sensitivity and related conditions, identifying new types of treatment for salt sensitivity and related conditions, and evaluating the effectiveness of treatments for conditions involving salt sensitivity (e.g., hypertension).
Method For Reducing Mortality With An Angiotensin Ii Antagonist
US Patent:
6201002, Mar 13, 2001
Filed:
Jan 6, 1998
Appl. No.:
9/003159
Inventors:
Polly A. Beere - Lahaska PA
Paul I. Chang - Doylestown PA
Bertram Pitt - Ann Arbor MI
Eva J. Rucinska - Blue Bell PA
Robert Segal - Gwynedd Valley PA
Divakar Sharma - Hatfield PA
Duane B. Snavely - Chalfont PA
Paul I. Chang - Doylestown PA
Bertram Pitt - Ann Arbor MI
Eva J. Rucinska - Blue Bell PA
Robert Segal - Gwynedd Valley PA
Divakar Sharma - Hatfield PA
Duane B. Snavely - Chalfont PA
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A01N 4350
US Classification:
514397
Abstract:
Angiotensin II receptor antagonists are useful in reducing and preventing mortality and sudden cardiac death in symptomatic heart failure patients. Losartan potassium has been shown to reduce mortality and sudden cardiac death in this patient population. Additionally, losartan potassium has been shown to reduce the need for hospitalization of symptomatic heart failure patients.
Compositions And Methods For Preserving Red Blood Cells
US Patent:
2010002, Jan 28, 2010
Filed:
Jan 17, 2008
Appl. No.:
12/521639
Inventors:
Maria Carolina Delgado - Doral FL, US
Bertram Pitt - Ann Arbor MI, US
Bertram Pitt - Ann Arbor MI, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
A01N 1/02
US Classification:
435 2
Abstract:
The present invention provides methods, compositions and kits for storing red blood cells for extended periods of time. In particular, the present invention provides methods, compositions and kits for storing red blood cells for extended periods of time while preventing red blood cell storage lesions, retaining red blood cell deformability, and increasing survival of the red blood cells following transfusion.
Compositions And Methods For Reducing Cardiovascular Morbidity And/Or Mortality
US Patent:
2008024, Oct 2, 2008
Filed:
Nov 29, 2007
Appl. No.:
11/867891
Inventors:
Kenneth Jamerson - West Bloomfield MI, US
Malcolm MacNab - Far Hills NJ, US
Bertram Pitt - Ann Arbor MI, US
Malcolm MacNab - Far Hills NJ, US
Bertram Pitt - Ann Arbor MI, US
International Classification:
A61K 31/55, A61P 9/12
US Classification:
51421207
Abstract:
The present invention is related to a method for reducing cardiovascular morbidity and/or mortality comprising administering a combination comprising an ACE inhibitor and a CCB, specifically benazapril and amlodipine besylate.
Compositions And Methods For Reducing Cardiovascular Morbidity And/Or Mortality
US Patent:
2006023, Oct 19, 2006
Filed:
Oct 20, 2004
Appl. No.:
10/969700
Inventors:
Kenneth Jamerson - West Bloomfield MI, US
Malcolm MacNab - Far Hills NJ, US
Bertram Pitt - Ann Arbor MI, US
Malcolm MacNab - Far Hills NJ, US
Bertram Pitt - Ann Arbor MI, US
International Classification:
A61K 31/704, A61K 31/549, A61K 31/455, A61K 31/401, A61K 9/20
US Classification:
424464000, 514026000, 514355000, 514423000, 514223500
Abstract:
The present invention is related to a method for reducing cardiovascular morbidity and/or mortality comprising administering a combination comprising an ACE inhibitor and a CCB, specifically benazapril and amlodipine besylate.